Overexpression of BRD7 can suppress tumor growth in vivo, and the inhibitory effect on tumor growth is more pronounced when BRD7 was overexpressed simultaneously with T cell injection, further enhanced by the use of Atezolizumab, which significantly inhibited tumor growth in vivo (Figure 6B-D). The gene discussed is BRD7; the disease is neoplasm.